Q4 2024 13F Holders as of 31 Dec 2024
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
9,783,925
-
Total 13F shares
-
30,029,181
-
Share change
-
+13,803,558
-
Total reported value
-
$7,723,566
-
Price per share
-
$0.26
-
Number of holders
-
25
-
Value change
-
+$3,536,854
-
Number of buys
-
14
-
Number of sells
-
9
Institutional Holders of IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) as of Q4 2024
As of 31 Dec 2024,
IN8BIO, INC. - Common Stock, par value $0.0001 per share (INAB) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
30,029,181 shares.
The largest 10 holders included
BIOS Capital Management, LP, AIGH Capital Management LLC, FRANKLIN RESOURCES INC, Alyeska Investment Group, L.P., VANGUARD GROUP INC, Sigma Planning Corp, 683 Capital Management, LLC, GEODE CAPITAL MANAGEMENT, LLC, Stonegate Investment Group, LLC, and JANE STREET GROUP, LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q4 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.